Stay updated on Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial
Sign up to get notified when there's something new on the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page.

Latest updates to the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study content with an access-denied message. This indicates the study record at this URL is currently inaccessible.SummaryDifference19%

- Check36 days agoChange DetectedA revision label on the page updated from v3.6.5 to v3.6.6, representing a minor version update to the page.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a software or UI update to the page.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page footer has been updated from Revision: v3.6.3 to Revision: v3.6.4, indicating a platform/UI update without altering the study information or eligibility details.SummaryDifference0.0%

- Check93 days agoChange DetectedThe page shows a new revision tag at the bottom, indicating an update to the study page (v3.6.3). This is a maintenance update and does not change the study details.SummaryDifference0.0%

- Check100 days agoChange DetectedThe page shows a new revision tag (v3.6.2) replacing the previous v3.6.0, indicating a software update to the page without altering study information.SummaryDifference0.0%

Stay in the know with updates to Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page.